CJC-1295 with DAC and Ipamorelin target the growth hormone axis through different, complementary pathways, creating a synergistic effect:
CJC-1295 (with DAC): This peptide is a long-acting analog of Growth Hormone-Releasing Hormone (GHRH). The “Drug Affinity Complex” (DAC) allows it to bind to albumin in the bloodstream, extending its half-life to about 6-8 days. This results in a sustained, steady elevation of baseline GH and IGF-1 levels over several days.
Ipamorelin: This is a selective ghrelin receptor agonist (GHRP). It has a short half-life (around 2 hours) and produces a rapid, time-limited pulse of GH release after dosing, without significantly impacting stress hormones like cortisol or prolactin.
Synergy: When used together, the sustained action of CJC-1295 provides a constant base level of GH, while Ipamorelin adds natural, pulsatile spikes, mimicking the body’s more youthful and vigorous GH release patterns.
| DOSAGE | 5MG |
|---|
